Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC37 Inhibitors

TTC37 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the Tetratricopeptide Repeat Domain 37 (TTC37) protein. TTC37 is involved in various cellular processes, particularly in RNA metabolism and protein-protein interactions. The protein contains multiple tetratricopeptide repeat (TPR) motifs, which are known to mediate protein-protein interactions that regulate several aspects of cellular function. TTC37 is a component of the Ski complex, which is involved in the exosome-mediated degradation of RNA, particularly in controlling the stability and turnover of messenger RNA (mRNA). By regulating RNA processing and degradation, TTC37 contributes to maintaining proper RNA levels within cells, influencing gene expression and cellular responses to changing conditions.

Inhibitors of TTC37 are typically designed to interfere with the protein's ability to form complexes with other proteins in the Ski complex or disrupt its role in RNA degradation. These compounds may bind to the TPR motifs or other functional domains essential for TTC37's interaction with its partners. By inhibiting TTC37, researchers can observe changes in RNA stability and degradation, providing insights into the regulatory mechanisms of RNA metabolism. Studying the effects of TTC37 inhibition also allows for a better understanding of its broader role in maintaining cellular homeostasis, as the Ski complex plays a key role in ensuring proper RNA processing. Through the use of TTC37 inhibitors, researchers can explore how this protein influences RNA decay, gene expression regulation, and the intricate balance of protein interactions within cells that depend on precise RNA control.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

May inhibit protein synthesis, potentially reducing TTC37 expression indirectly through global translational inhibition.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Could inhibit proteasome activity, possibly affecting TTC37 degradation and turnover.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Might affect lysosomal function, potentially influencing TTC37 degradation.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

May interfere with nucleotide synthesis, possibly affecting TTC37 mRNA synthesis and stability.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Could bind to DNA, inhibiting transcription and potentially reducing TTC37 mRNA synthesis.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

As a proteasome inhibitor, it might impact the degradation and turnover of TTC37.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Might inhibit mTOR pathway, potentially influencing TTC37 protein synthesis.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Could crosslink DNA, potentially affecting transcription and the expression of TTC37.

Emetine

483-18-1sc-470668
sc-470668A
sc-470668B
sc-470668C
1 mg
10 mg
50 mg
100 mg
$440.00
$900.00
$1400.00
$2502.00
(0)

May inhibit protein synthesis, possibly affecting the expression levels of TTC37.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(15)

Might cause premature chain termination during translation, affecting TTC37 protein synthesis.